← Browse by Condition
Medical Condition
itp immune thrombocytopenia
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2, Phase 3, Phase 4
ClinicalMetric tracks all active clinical trials for itp immune thrombocytopenia sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 1
Phase 2 1
Phase 3 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07083960 Phase 1
Recruiting
OM336 in Autoimmune Cytopenias
Enrollment
32 pts
Location
Australia
Sponsor
Ouro Medicines
NCT06813157
Recruiting
Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia
Enrollment
40 pts
Location
China
Sponsor
Guangzhou Bio-gene Technology ...
NCT07194850 Phase 2, Phase 3
Recruiting
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
Enrollment
24 pts
Location
Italy, Poland, Roman...
Sponsor
argenx
NCT07133659 Phase 4
Recruiting
Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study
Enrollment
25 pts
Location
Iraq
Sponsor
Al-Mustansiriyah University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology